Březina, J.; Bajer, L.; Wohl, P.; Ďuricová, D.; Hrabák, P.; Novotný, A.; Koželuhová, J.; Lukáš, M.; Mrázek, J.; Fliegerová, K.O.;
et al. Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial. J. Clin. Med. 2021, 10, 2753.
https://doi.org/10.3390/jcm10132753
AMA Style
Březina J, Bajer L, Wohl P, Ďuricová D, Hrabák P, Novotný A, Koželuhová J, Lukáš M, Mrázek J, Fliegerová KO,
et al. Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial. Journal of Clinical Medicine. 2021; 10(13):2753.
https://doi.org/10.3390/jcm10132753
Chicago/Turabian Style
Březina, Jan, Lukáš Bajer, Pavel Wohl, Dana Ďuricová, Pavel Hrabák, Aleš Novotný, Jana Koželuhová, Milan Lukáš, Jakub Mrázek, Kateřina Olša Fliegerová,
and et al. 2021. "Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial" Journal of Clinical Medicine 10, no. 13: 2753.
https://doi.org/10.3390/jcm10132753
APA Style
Březina, J., Bajer, L., Wohl, P., Ďuricová, D., Hrabák, P., Novotný, A., Koželuhová, J., Lukáš, M., Mrázek, J., Fliegerová, K. O., Kvasnová, S., Chahrazed, M., Mareš, J., Špičák, J., & Drastich, P.
(2021). Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial. Journal of Clinical Medicine, 10(13), 2753.
https://doi.org/10.3390/jcm10132753